The current use of enormously expanded NK cells for NK cell-mediated cancer immunotherapy highlights the potential impact of TNFR2 signaling in ensuring the extensive proliferation and expansion of NK cells, which could be crucial for the development of effective immunotherapeutic strategies. The gene discussed is TNFRSF1B; the disease is cancer.